This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
General Information
Mouse: C57BL6/J
Mice in which exon 7 of the DJ-1 gene were deleted leading to the absence of DJ-1 protein in homozygous DJ-1-/- mice. Male and female mice are fertile, show no changes in weight gain compared to wt mice, and comparable life span.
Endogenous DJ-1: No
Corresponding human genotype: Autosomal recessive genetic deletion in the DJ-1 gene causing a loss-of-function of the protein and leading to early-onset Parkinson’s disease (PARK7).
Mutated gene: DJ-1
References: Manning-Bog 2007
Neurodegeneration
- 3-4 months: No apparent changes in the number TH-positive neurons. MPTP treatment induces a more severe loss of TH-positive terminals in the striatum but not of TH-positive neurons in the SN.
Increased DAT function is observed (causing higher MPTP uptake and toxicity)
Dopamine Homeostasis
- 3-4 months: No apparent changes DA and DA metabolites levels are observed. Increased DA reuptake is observed. MPTP treatment induces a more severe depletion of DA and DA metabolites in KO mice compared to wt mice (likely linked to increased DAT function in KO mice).
Inclusions
- Not reported
Motor Behaviours
- 3-4 and 12 months: No motor deficits are observed (inverted grid, stride length).
- 12 months: slight increase in forepaw faults is observed.
Response to dopaminergic treatment
- Not reported
Non motor Behaviours
- Not reported
Electrophysiology
- Not reported
Neuroinflammation
- 3-4 months: No apparent astroglial activation is obsevred in the SN following MPTP treatment
Updated 25/04/2018
